TELAVINCE AF25: Tenofovir Alafenamide 25mg — Uses, Benefits & Substitutes

 TELAVINCE AF25, manufactured by Steris Healthcare, contains Tenofovir Alafenamide 25 mg, a nucleotide reverse transcriptase inhibitor (antiviral) prescribed for the treatment of chronic Hepatitis B virus (HBV) infection in adults with compensated liver disease. It works by suppressing viral replication, helping reduce liver inflammation, slow disease progression, and lower the long-term risk of complications such as cirrhosis and liver cancer associated with untreated chronic Hepatitis B. Tenofovir Alafenamide represents a newer-generation prodrug formulation designed to deliver the active antiviral compound more efficiently to liver cells at a lower overall dose compared to earlier tenofovir formulations.

Why It's Important

Chronic Hepatitis B is a major global health concern, with long-term untreated infection carrying significant risk of progressive liver damage, cirrhosis, and hepatocellular carcinoma. Effective antiviral suppression is essential to reducing this risk, but earlier tenofovir formulations were associated with certain renal and bone-related concerns with long-term use, particularly relevant for patients requiring lifelong therapy. TELAVINCE AF25's tenofovir alafenamide formulation is important because it achieves effective viral suppression at a substantially lower plasma drug concentration than older formulations, while still delivering high intracellular concentrations of the active antiviral compound directly within liver cells — offering a more favorable long-term safety profile for renal function and bone mineral density, both important considerations for patients on extended treatment courses.

Key Benefits 

What are the benefits?

  • Effectively suppresses Hepatitis B viral replication
  • Helps reduce liver inflammation and slow disease progression
  • Lower dose requirement with improved renal and bone safety profile
  • Suitable for long-term chronic Hepatitis B management
  • Manufactured under WHO-GMP and ISO 9001:2018 certified facility standards by Steris Healthcare, ensuring consistent potency and quality

Side Effects

Common side effects may include nausea, headache, fatigue, and mild abdominal discomfort, generally manageable and often improving with continued use.

Serious Side Effects 

Seek immediate medical attention for signs of lactic acidosis (unusual muscle pain, difficulty breathing, severe fatigue), worsening liver function after stopping treatment, signs of kidney problems (reduced urination, swelling), or signs of a severe allergic reaction.

Available Substitute 

Several branded Tenofovir Alafenamide formulations are available in the Indian market at comparable strengths. Brand switches should only be made under physician guidance to maintain consistent viral suppression.

Dosage Guidelines 

Dosage is individualized by the treating hepatologist or physician, typically taken once daily with food. Treatment duration is generally long-term, guided by ongoing monitoring of viral load and liver function. Missed doses should be taken as soon as remembered, without doubling the next dose.

Precautions & Warnings

Use cautiously in patients with pre-existing renal impairment, and monitor liver function closely, particularly after discontinuation, as Hepatitis B flares can occur. This medication should not be abruptly stopped without physician guidance. Inform your doctor of all current medications and any co-existing HIV infection status before starting therapy.

Mechanism of Action

Tenofovir Alafenamide is a prodrug that is converted intracellularly to tenofovir diphosphate, which competitively inhibits HBV reverse transcriptase, incorporating into viral DNA and causing chain termination. This effectively halts viral replication, allowing the immune system and liver to recover from ongoing HBV-related inflammation over time.

Conclusion

TELAVINCE AF25 by Steris Healthcare offers an effective, next-generation antiviral therapy for chronic Hepatitis B management, combining strong viral suppression with an improved long-term safety profile. Treatment should be initiated and monitored under the close guidance of a qualified physician for optimal outcomes.

Comments

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness